Physician profile
Forrest J Pratt
NPI 1184156127
$14,605.88
in general payments reported to CMS, 2019-2025
10 companies · $436 in 2025
The $436 reported for 2025 was more than what 76% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.63 · 2022: $14K · 2023: $295 · 2024: $77.37 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $808.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $808.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $13,776.74 | 2021-2022 | |
| Acumed LLC | $373.31 | 2023-2025 | Osteomed |
| Dentsply Sirona INC | $183.58 | 2025 | Implant Dentistry |
| Southern Anesthesia & Surgical, INC (Dba Ace Southern) | $60.83 | 2023 | |
| Stryker Corporation | $59.65 | 2024 | Na |
| Geistlich Pharma, North America, INC. | $52.66 | 2025 | Biomaterials |
| Straumann USA LLC | $39.01 | 2023 | |
| Biohorizons Implant Systems INC. | $21.39 | 2025 | Biohorizons Dental Implants |
| Pacira Pharmaceuticals Incorporated | $20.99 | 2022 | |
| Envista Holdings Corporation | $17.72 | 2024 | Spark |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Forrest Pratt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.